C Huang

High expression of nuclear factor of activated T cells in Chinese primary non-small cell lung cancer tissues.

Z Chen, S. Shi, F. Zhou, 2007, The International journal of biological markers.

Feasibility study of FDG PET/CT-derived primary tumour glycolysis as a prognostic indicator of survival in patients with non-small-cell lung cancer.

C Huang, G Mehta, A Chander, 2014, Clinical radiology.

Prognostic significance of angiogenesis in human pancreatic cancer

M. Adachi, C. Huang, Y. Nakajima, 1999, British Journal of Cancer.

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study.

B. Han, G. Jiang, H. Pan, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803).

Yi-long Wu, Y. Wu, C. Zhou, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.